These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20860640)
1. Association of warfarin use with CHADS(2) score in 441 patients with nonvalvular atrial fibrillation and no contraindications to warfarin. Desai HV; Aronow WS; Gandhi K; Bakerywala S; Laimuanpuii J; Sharma M; Peterson SJ Prev Cardiol; 2010; 13(4):172-4. PubMed ID: 20860640 [TBL] [Abstract][Full Text] [Related]
2. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
4. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237 [TBL] [Abstract][Full Text] [Related]
5. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S; Bennett D; Smith DJ Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933 [TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564 [TBL] [Abstract][Full Text] [Related]
7. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes. Lopes RD; Starr A; Pieper CF; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Mahaffey KW; Armstrong PW; Harrington RA; White HD; Wallentin L; Granger CB Am J Med; 2010 Feb; 123(2):134-40. PubMed ID: 20103022 [TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518 [TBL] [Abstract][Full Text] [Related]
9. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL; Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665 [TBL] [Abstract][Full Text] [Related]
10. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
11. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
12. Stroke prevention in elderly patients with atrial fibrillation. Lew SJ; Lim JK Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065 [TBL] [Abstract][Full Text] [Related]
13. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823 [TBL] [Abstract][Full Text] [Related]
14. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. Choudhury A; Chung I; Blann AD; Lip GY J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation. Lleva P; Aronow WS; Gutwein AH Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities. Singh P; Arrevad PS; Peterson GM; Bereznicki LR J Clin Pharm Ther; 2011 Apr; 36(2):166-71. PubMed ID: 21366645 [TBL] [Abstract][Full Text] [Related]
17. Quality of care for atrial fibrillation among patients hospitalized for heart failure. Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC; J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670 [TBL] [Abstract][Full Text] [Related]
18. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation. Morrison CM; Gainsborough N; Rajkumar C Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089 [No Abstract] [Full Text] [Related]
19. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan. Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379 [TBL] [Abstract][Full Text] [Related]
20. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital. Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]